Growth Metrics

Mannkind (MNKD) Cash & Current Investments (2010 - 2026)

Mannkind (MNKD) reported Cash & Current Investments of $134.6 million for Q1 2026, down 26.15% year-over-year from $182.3 million in Q1 2025, and down 21.44% on a QoQ basis from $171.3 million in Q4 2025.

Mannkind (MNKD) has 17 years of Cash & Current Investments data on file, last reported at $134.6 million in Q1 2026.

  • Quarterly Cash & Current Investments fell 26.15% year-over-year to $134.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $134.6 million (down 26.15% YoY) and the FY2025 annual result came in at $171.3 million, down 13.46% from the prior year.
  • Cash & Current Investments slipped to $134.6 million in Q1 2026 per MNKD's latest filing, from $171.3 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $300.7 million in Q1 2024 and bottomed at $134.6 million in Q1 2026.
  • The 5-year median for Cash & Current Investments is $171.3 million (2025), against an average of $195.6 million.
  • The widest annual swing landed in 2022, when Cash & Current Investments sank 41.34%; it then jumped 81.01% in 2024.
  • Tracing MNKD's Cash & Current Investments over 5 years: stood at $170.8 million in 2022, then surged by 72.73% to $295.1 million in 2023, then sank by 32.91% to $198.0 million in 2024, then decreased by 13.46% to $171.3 million in 2025, then retreated by 21.44% to $134.6 million in 2026.
  • Per Business Quant, the three latest MNKD Cash & Current Investments figures stand at $134.6 million (Q1 2026), $171.3 million (Q4 2025), and $260.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 2.13 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 32.30 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 286.70 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 61.46 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 2.77 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 7.25 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - 18.44 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 8.75 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 3.01 Bn
10 Mannkind 1.09 Bn 956.66 Mn 82.66 Mn 134.61 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 134.61 Mn
Dec 31, 2025 171.35 Mn
Sep 30, 2025 260.04 Mn
Jun 30, 2025 178.99 Mn
Mar 31, 2025 182.28 Mn
Dec 31, 2024 197.99 Mn
Sep 30, 2024 252.32 Mn
Jun 30, 2024 248.49 Mn
Mar 31, 2024 300.73 Mn
Dec 31, 2023 295.10 Mn
Sep 30, 2023 141.02 Mn
Jun 30, 2023 144.35 Mn
Mar 31, 2023 166.14 Mn
Dec 31, 2022 170.85 Mn
Sep 30, 2022 165.05 Mn
Jun 30, 2022 154.15 Mn
Mar 31, 2022 162.40 Mn
Dec 31, 2021 204.12 Mn
Sep 30, 2021 139.01 Mn
Jun 30, 2021 162.47 Mn
Mar 31, 2021 276.83 Mn
Dec 31, 2020 67.16 Mn
Sep 30, 2020 52.71 Mn
Jun 30, 2020 63.54 Mn
Mar 31, 2020 38.87 Mn
Dec 31, 2019 49.91 Mn
Sep 30, 2019 50.06 Mn
Jun 30, 2019 13.28 Mn
Mar 31, 2019 59.29 Mn
Dec 31, 2018 71.68 Mn
Sep 30, 2018 10.97 Mn
Jun 30, 2018 26.71 Mn
Mar 31, 2018 27.23 Mn
Dec 31, 2017 48.36 Mn
Sep 30, 2017 10.00 Mn
Jun 30, 2017 43.38 Mn
Mar 31, 2017 47.98 Mn
Dec 31, 2016 22.90 Mn
Sep 30, 2016 35.53 Mn
Jun 30, 2016 63.73 Mn
Mar 31, 2016 27.65 Mn
Dec 31, 2015 59.07 Mn
Sep 30, 2015 32.93 Mn
Jun 30, 2015 107.19 Mn
Mar 31, 2015 120.84 Mn
Dec 31, 2014 120.84 Mn
Sep 30, 2014 172.47 Mn
Jun 30, 2014 41.21 Mn
Mar 31, 2014 35.76 Mn
Dec 31, 2013 70.79 Mn
Sep 30, 2013 93.80 Mn
Jun 30, 2013 28.53 Mn
Mar 31, 2013 28.01 Mn
Dec 31, 2012 61.84 Mn
Sep 30, 2012 2.12 Mn
Jun 30, 2012 31.99 Mn
Mar 31, 2012 56.71 Mn
Dec 31, 2011 3.20 Mn
Sep 30, 2011 23.30 Mn
Jun 30, 2011 25.27 Mn
Mar 31, 2011 46.91 Mn
Dec 31, 2010 70.43 Mn
Sep 30, 2010 97.93 Mn
Jun 30, 2010 28.36 Mn